Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Site News
Market: Market:

Delcath Systems Inc (DCTH)

Delcath Systems Inc (DCTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Positive Initial Results from CHOPIN Phase 1b Trial, FOCUS Trial Update and QoL Study Presented at the 2022 ASCO Annual Meeting Globe Newswire - Mon Jun 6, 3:15PM CDT

Initial results from the Phase 1b portion of the CHOPIN trial of PHP in combination with ipilimumab plus nivolumab in advanced uveal melanoma in seven...

DCTH : 3.99 (-2.56%)
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates Zacks - Tue May 10, 7:55AM CDT

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of -19.05% and 70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

DCTH : 3.99 (-2.56%)
AWH : 0.6313 (-6.89%)
Delcath Systems Reports First Quarter 2022 Results and Provides Business Update Globe Newswire - Tue May 10, 6:30AM CDT

NEW YORK , May 10, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

DCTH : 3.99 (-2.56%)
Delcath Announces Poster Presentation at the 2022 ASCO Annual Meeting Globe Newswire - Mon May 9, 7:30AM CDT

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

DCTH : 3.99 (-2.56%)
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates Zacks - Fri May 6, 7:15AM CDT

Orthofix (OFIX) delivered earnings and revenue surprises of -155.56% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OFIX : 23.55 (-0.84%)
DCTH : 3.99 (-2.56%)
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates Zacks - Wed May 4, 5:05PM CDT

Pacific Biosciences (PACB) delivered earnings and revenue surprises of -15.63% and 1.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PACB : 4.57 (-5.97%)
DCTH : 3.99 (-2.56%)
Delcath Systems to Host First Quarter 2022 Results Globe Newswire - Thu Apr 28, 8:00AM CDT

NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

DCTH : 3.99 (-2.56%)
Delcath Systems to Participate in the Canaccord Genuity Horizons in Oncology Conference Globe Newswire - Fri Apr 8, 8:00AM CDT

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

DCTH : 3.99 (-2.56%)
Delcath Systems to Participate in the Lytham Partners Spring 2022 Investor Conference Globe Newswire - Tue Mar 29, 8:00AM CDT

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

DCTH : 3.99 (-2.56%)
Delcath Systems, Inc. (DCTH) Reports Q4 Loss, Tops Revenue Estimates Zacks - Fri Mar 25, 8:05AM CDT

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of 25.81% and 285.38%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?...

DCTH : 3.99 (-2.56%)
EW : 96.03 (+1.37%)

Barchart Exclusives

Morgan Stanley vs. Goldman Sachs: Which Is the Better Dividend Buy? Barchart - Wed Jun 29, 2:50PM CDT
Goldman Sachs (GS) raised its quarterly dividend by 25%. Morgan Stanley (MS) increased its dividend by almost 11%. They both seem like compelling dividend plays. So, which is the better buy? Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' : 'America/Chicago' ]] CDT
Reserve Your Spot